Menu
ARE YOU AGED BETWEEN 50 and 80 YEARS OLD? ARE YOU FULLY VACCINATED AGAINST COVID-19 (with or without a booster)? You may qualify* to take part in a trial for …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Completed
An Australian researcher is testing an investigational product (Hidracare). In this study, we are trying to find out if Hidracare solution, a salt mixture, could improve the skin condition Hidradentitis …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP: 30 to 65 years
TRIAL STATUS: Completed
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Scientia Clinical trial is seeking participants to join a clinical trial. The clinical trial involves wearing a patch for one week. Participants will need to be available for 10 days …
CONDITION: Other
GENDER: Females
AGE GROUP: 25 to 50 years
TRIAL STATUS: Completed
We are testing a treatment developed for polycythemia vera, which is a condition that has limited therapeutic options and no cure is currently available. The medication will be administered subcutaneously …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 50 years
TRIAL STATUS: Completed
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 to 80 years
TRIAL STATUS: Completed
Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 50 and above
TRIAL STATUS: Completed
This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 50 and above
TRIAL STATUS: Completed
The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …
CONDITION: Cancer
GENDER: Males
AGE GROUP: 18 and above
TRIAL STATUS: Completed
An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind, …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Completed
A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This study will determine if NAC is an effective treatment for …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Completed
This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Completed
Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 9 and above
TRIAL STATUS: Completed
Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 to 100 years
TRIAL STATUS: Completed
20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 45 years
TRIAL STATUS: Completed
This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 and above
TRIAL STATUS: Completed
people suffering with Acute Pain 1 visit of approximately 2 hours assessing a survey for people affected by Acute Pain in Australia If you suffer from Acute Pain or know someone who does, contact us for …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed